Malawi launches twice-yearly HIV jab
Malawi yesterday launched Lenacapavir, a twice-yearly injectable HIV prevention medicine amid reflections on whether the country can sustainably finance emerging technolo...
Malawi yesterday launched Lenacapavir, a twice-yearly injectable HIV prevention medicine amid reflections on whether the country can sustainably finance emerging technolo...
You can now be vaccinated against HIV – but that does not mean you can be reckless, warns the Department of Healthscientist-hiv-vaccinationA scientist holds a batch of...
THE Medicines Control Authority of Zimbabwe (MCAZ) has approved a new long-acting medicine, Lenacapavir, to help prevent HIV infection.Lenacapavir, is used for pre-exposu...
Minister of Health, Dr Jane Ruth Aceng, has welcomed a landmark global deal that will dramatically slash the cost of the HIV prevention drug, lenacapavir, making it affor...
USAID road localisation show. USAID had embarked on funding locally lead initiatives across Uganda. PHOTO URNKampala, Uganda | USAID has been present in Uganda for over...
KAMPALA, Uganda – June 29, 2025 – The Uganda AIDS Commission today announced the successful conclusion of research on Lenacapavir, a groundbreaking six-monthly inject...
The future may be getting brighter in terms of reducing the threat of the human immunodeficiency virus (HIV), infectious disease experts told Newsweek.With new treatments...